A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
NCT07881887
This study is recruiting at 12 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The main purpose of this study is to look at how safe and well-tolerated LY4167586 is in participants with obesity or overweight with or without Type 2 Diabetes. Blood tests will be performed to check how much LY4167586 gets into the bloodstream and how long it takes the body to eliminate it following a single administration. Participation in the study will last between approximately 53 to 89 weeks. For each participant (excluding those in Part B), the study will include between 5 and 7 stays in the Clinical Research Unit (CRU), each stay lasting between approximately 8 and 10 nights.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Obesity
- Overweight
- Diabetes Mellitus, Type 2
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Eli Lilly and Company
- Last updated on ClinicalTrials.gov
- November 18, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 3
- CenExel ACT · Anaheim, CA
- Collaborative Neuroscience Network - CNS · Los Alamitos, CA
- Diablo Clinical Research, Inc. · Walnut Creek, CA
Florida · 2
- Fortrea Clinical Research Unit · Daytona Beach, FL
- Clinical Site Partners, LLC DBA CSP Orlando · Winter Park, FL
Georgia · 2
- Centricity Research · Columbus, GA
- CenExel iResearch, LLC · Decatur, GA
Missouri · 1
- QPS · Springfield, MO
New Jersey · 1
- CenExel-HRI · Marlton, NJ
Ohio · 1
- Ohio Clinical Trials · Columbus, OH
Texas · 2
- Fortrea Clinical Research Unit · Dallas, TX
- Worldwide Clinical Trials, Inc. · San Antonio, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.